Spreadsheet: f99cf1ee-2340-4022-9b90-60cdf07b4fbb
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
HCCD | Test | HCCD | Hereditary Colon Cancer Multi-Gene Large Deletion and Duplication Analysis | Hereditary Colon Cancer Del/Dup | Gene Dosage Analysis by [NAME] Genomic Hybridization (aCGH) or Polymerase Chain Reaction (PCR) followed by [NAME] (MLPA) (PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.) | EDTA (lavender-top) tube: EDTA Yellow-Top (ACD) Tube: ACD |  |  | 1 | mL | [NAME] must arrive within 96 hours of collection.   [NAME] blood Container/Tube: Preferred: Lavender top (EDTA) or yellow top (ACD) Acceptable: Any anticoagulant  [NAME]: 3 mL Collection Instructions:	 1. Invert several times to mix blood. 2. Send specimen in original tube. Additional Information: To ensure minimum volume and concentration of DNA are met, the preferred volume of blood must be submitted. Testing maybe canceled if DNA requirements are inadequate. Forms: 1. New York Clients-Informed consent is required. Please document on the request form or electronic order that a copy is on file. An Informed Consent for Genetic Testing (Supply T576) is available in Special Instructions. 2. Molecular Genetics-Colon Cancer Patient Information Sheet (Supply T521) in Special Instructions | 1 mL | No specimen should be rejected. If specimen is received in wrong anticoagulant or at an inappropriate temperature, include note to laboratory. If questions, contact the laboratory. | An interpretive report will be provided. | Varies, weekly to every other week based on sample volume, will be run twice a month at minimum | 2 weeks | 3 weeks |  | Profile |  |  |  |  | Rochester
HCCD | [NAME] | VARIES | Varies |  |  |  | Ambient
HCCD | Result | 51418 | Reason for Referral | Reason for Referral | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 42349-1 | Reason for referral:Find:Pt:^Patient:Nar:
HCCD | Result | 51419 | Result | Result | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
HCCD | Result | 51420 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 69047-9 | Geneticist review:Imp:Pt:XXX:Nar:
HCCD | Result | 51421 | Caution | Caution | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
HCCD | Result | 51422 | Method | Method | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49549-9 | Reference lab test method:Type:XXX:Reference lab test:Nar:
HCCD | Result | 51423 | Amendment | Amendment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
HCCD | Result | 51424 | [NAME] | [NAME] | Alphanumeric
HCCD | Result | 51425 | Source | Source | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 31208-2 | [NAME] source:Prid:Pt:[NAME]:Nom:
HCCD | Result | 51426 | Reviewed By | Reviewed By | Alphanumeric
HCCD | Result | 51427 | Release Date | Release Date | Alphanumeric
HCCD | Billing Component | HCCD |  | PMS2 GENE DUP/DELET VARIANTS |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 81319
HCCD | Billing Component | HCCD |  | CYTOGEN MICRARRAY COPY NMBR |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 81228